Rheumatoid arthritis: an infographic

Illustrating insights that can make a difference

December 27, 2017

Related research

Prime analysis

January 18, 2022

Biosimilar strategy for infliximab by MedDrive™ includes the reference drug

The U.S. Food and Drug Administration (FDA) first approved Janssen Biotech’s Remicade® (infliximab)…

Prime analysis

December 14, 2021

Biosimilar strategy for rituximab using MedDrive™

Rituxan® (rituximab) from Genentech was first approved by the FDA in 1997 for…

Prime analysis

December 7, 2021

Biosimilar strategy for trastuzumab using MedDrive™

Herceptin® (trastuzumab) from Genentech is a targeted cancer drug used primarily to treat…